Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation

Fu Fei Hsu, Yi Tai Chou, Ming Tsai Chiang, Fu An Li, Chi Tai Yeh, Wei Hwa Lee, Lee Young Chau

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Signal peptide peptidase (SPP) is an endoplasmic reticulum (ER)-resident aspartyl protease mediating intramembrane cleavage of type II transmembrane proteins. Increasing evidence has supported the role of SPP in ER-associated protein degradation. In the present study, we show that SPP expression is highly induced in human lung and breast cancers and correlated with disease outcome. Stable depletion of SPP expression in lung and breast cancer cell lines significantly reduced cell growth and migration/invasion abilities. Quantitative analysis of the proteomic changes of microsomal proteins in lung cancer cells by the stable isotope labeling with amino acids in cell culture (SILAC) approach revealed that the level of FKBP8, an endogenous inhibitor of mTOR, was significantly increased following SPP depletion. Co-immunoprecipitation assay and confocal immunofluorescence demonstrated that SPP interacted and colocalized with FKBP8 in ER, supporting that FKBP8 is a protein substrate of SPP. Cycloheximide chase and proteasome inhibition experiments revealed that SPP-mediated proteolysis facilitated FKBP8 protein degradation in cytosol. Further experiment demonstrated that the levels of phosphorylation in mTOR and its downstream effectors, S6K and 4E-BP1, were significantly lower in SPP-depleted cells. The reduced mTOR signaling and decreases of growth and migration/invasion abilities induced by SPP depletion in cancer cells could be reversed by FKBP8 downregulation. The implication of FKBP8 in SPP-mediated tumorigenicity was also observed in the xenograft model. Together, these findings disclose that SPP promotes tumor progression, at least in part, via facilitating the degradation of FKBP8 to enhance mTOR signaling.

Original languageEnglish
JournalOncogene
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Neoplasms
Proteolysis
Lung Neoplasms
Endoplasmic Reticulum
signal peptide peptidase
Endoplasmic Reticulum-Associated Degradation
Breast Neoplasms
Aspartic Acid Proteases
Isotope Labeling
Proteins
Proteasome Endopeptidase Complex
Cycloheximide
Growth
Immunoprecipitation
Heterografts
Cytosol
Proteomics
Cell Movement
Fluorescent Antibody Technique
Down-Regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation. / Hsu, Fu Fei; Chou, Yi Tai; Chiang, Ming Tsai; Li, Fu An; Yeh, Chi Tai; Lee, Wei Hwa; Chau, Lee Young.

In: Oncogene, 01.01.2018.

Research output: Contribution to journalArticle

Hsu, Fu Fei ; Chou, Yi Tai ; Chiang, Ming Tsai ; Li, Fu An ; Yeh, Chi Tai ; Lee, Wei Hwa ; Chau, Lee Young. / Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation. In: Oncogene. 2018.
@article{b6ad45e6942c46d38c8b8e3c04571e1a,
title = "Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation",
abstract = "Signal peptide peptidase (SPP) is an endoplasmic reticulum (ER)-resident aspartyl protease mediating intramembrane cleavage of type II transmembrane proteins. Increasing evidence has supported the role of SPP in ER-associated protein degradation. In the present study, we show that SPP expression is highly induced in human lung and breast cancers and correlated with disease outcome. Stable depletion of SPP expression in lung and breast cancer cell lines significantly reduced cell growth and migration/invasion abilities. Quantitative analysis of the proteomic changes of microsomal proteins in lung cancer cells by the stable isotope labeling with amino acids in cell culture (SILAC) approach revealed that the level of FKBP8, an endogenous inhibitor of mTOR, was significantly increased following SPP depletion. Co-immunoprecipitation assay and confocal immunofluorescence demonstrated that SPP interacted and colocalized with FKBP8 in ER, supporting that FKBP8 is a protein substrate of SPP. Cycloheximide chase and proteasome inhibition experiments revealed that SPP-mediated proteolysis facilitated FKBP8 protein degradation in cytosol. Further experiment demonstrated that the levels of phosphorylation in mTOR and its downstream effectors, S6K and 4E-BP1, were significantly lower in SPP-depleted cells. The reduced mTOR signaling and decreases of growth and migration/invasion abilities induced by SPP depletion in cancer cells could be reversed by FKBP8 downregulation. The implication of FKBP8 in SPP-mediated tumorigenicity was also observed in the xenograft model. Together, these findings disclose that SPP promotes tumor progression, at least in part, via facilitating the degradation of FKBP8 to enhance mTOR signaling.",
author = "Hsu, {Fu Fei} and Chou, {Yi Tai} and Chiang, {Ming Tsai} and Li, {Fu An} and Yeh, {Chi Tai} and Lee, {Wei Hwa} and Chau, {Lee Young}",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/s41388-018-0539-y",
language = "English",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation

AU - Hsu, Fu Fei

AU - Chou, Yi Tai

AU - Chiang, Ming Tsai

AU - Li, Fu An

AU - Yeh, Chi Tai

AU - Lee, Wei Hwa

AU - Chau, Lee Young

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Signal peptide peptidase (SPP) is an endoplasmic reticulum (ER)-resident aspartyl protease mediating intramembrane cleavage of type II transmembrane proteins. Increasing evidence has supported the role of SPP in ER-associated protein degradation. In the present study, we show that SPP expression is highly induced in human lung and breast cancers and correlated with disease outcome. Stable depletion of SPP expression in lung and breast cancer cell lines significantly reduced cell growth and migration/invasion abilities. Quantitative analysis of the proteomic changes of microsomal proteins in lung cancer cells by the stable isotope labeling with amino acids in cell culture (SILAC) approach revealed that the level of FKBP8, an endogenous inhibitor of mTOR, was significantly increased following SPP depletion. Co-immunoprecipitation assay and confocal immunofluorescence demonstrated that SPP interacted and colocalized with FKBP8 in ER, supporting that FKBP8 is a protein substrate of SPP. Cycloheximide chase and proteasome inhibition experiments revealed that SPP-mediated proteolysis facilitated FKBP8 protein degradation in cytosol. Further experiment demonstrated that the levels of phosphorylation in mTOR and its downstream effectors, S6K and 4E-BP1, were significantly lower in SPP-depleted cells. The reduced mTOR signaling and decreases of growth and migration/invasion abilities induced by SPP depletion in cancer cells could be reversed by FKBP8 downregulation. The implication of FKBP8 in SPP-mediated tumorigenicity was also observed in the xenograft model. Together, these findings disclose that SPP promotes tumor progression, at least in part, via facilitating the degradation of FKBP8 to enhance mTOR signaling.

AB - Signal peptide peptidase (SPP) is an endoplasmic reticulum (ER)-resident aspartyl protease mediating intramembrane cleavage of type II transmembrane proteins. Increasing evidence has supported the role of SPP in ER-associated protein degradation. In the present study, we show that SPP expression is highly induced in human lung and breast cancers and correlated with disease outcome. Stable depletion of SPP expression in lung and breast cancer cell lines significantly reduced cell growth and migration/invasion abilities. Quantitative analysis of the proteomic changes of microsomal proteins in lung cancer cells by the stable isotope labeling with amino acids in cell culture (SILAC) approach revealed that the level of FKBP8, an endogenous inhibitor of mTOR, was significantly increased following SPP depletion. Co-immunoprecipitation assay and confocal immunofluorescence demonstrated that SPP interacted and colocalized with FKBP8 in ER, supporting that FKBP8 is a protein substrate of SPP. Cycloheximide chase and proteasome inhibition experiments revealed that SPP-mediated proteolysis facilitated FKBP8 protein degradation in cytosol. Further experiment demonstrated that the levels of phosphorylation in mTOR and its downstream effectors, S6K and 4E-BP1, were significantly lower in SPP-depleted cells. The reduced mTOR signaling and decreases of growth and migration/invasion abilities induced by SPP depletion in cancer cells could be reversed by FKBP8 downregulation. The implication of FKBP8 in SPP-mediated tumorigenicity was also observed in the xenograft model. Together, these findings disclose that SPP promotes tumor progression, at least in part, via facilitating the degradation of FKBP8 to enhance mTOR signaling.

UR - http://www.scopus.com/inward/record.url?scp=85055270438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055270438&partnerID=8YFLogxK

U2 - 10.1038/s41388-018-0539-y

DO - 10.1038/s41388-018-0539-y

M3 - Article

JO - Oncogene

JF - Oncogene

SN - 0950-9232

ER -